Methylation status of the fragile histidine triad and E-cadherin genes in plasma of cervical cancer patients

International Journal of Gynecological Cancer

Volumn 16, Issue 5, 2006, Pages 1862-1867

  Ren, C C ^a,b   Miao, X H ^b   Yang, B ^b   Zhao, L ^b   Sun, R ^b   Song, W Q ^b  

^a Tianjin Central Hospital of Obstetrics and Gynecology   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

Cervical cancer; E cadherin gene; FHIT gene; Methylation status

Indexed keywords

BIOLOGICAL MARKER; FRAGILE HISTIDINE TRIAD PROTEIN; UVOMORULIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER PATIENT; CANCER TISSUE; CONTROLLED STUDY; CPG ISLAND; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; DNA METHYLATION; FEMALE; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR CLONING; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ACID ANHYDRIDE HYDROLASES; ADULT; AGED; BASE SEQUENCE; CADHERINS; CARCINOMA, SQUAMOUS CELL; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS;

EID: 33749133448     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00669.x     Document Type: Article

References (13)

1. NIH. Cervical cancer. NIH Consensus Statement 1996;14:1-38.
2. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: The size of the problem. Best Pract Res Clin Obstet Gynaecol 2006;20:207-25.
3. Waggoner SE. Cervical cancer. Lancet 2003;361:2217-25.
4. Chen Q, Lipkina G, Song Q, Kramer RH. Promoter methylation regulates cadherin switching in squamous cell carcinoma. Biochem Biophys Res Commun 2004;315:850-6.
5. Yang HJ, Liu VWS, Wang Y et al. Detection of hypermethylated genes in tumor and plasma of cervical cancer patients. Gynecol Oncol 2004;93:435-40.
6. Shi HR, Wu QH, Suo ZH, John MN. Correlation between methylation of 5′-CpG islands and inactivation of FHIT gene in cervical cancer. Chin J Cancer 2005;24:7-11.
7. Chen CL, Liu SS, Ip SM, Wong LC, Ng TY, Ngan HYS. E-Cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumors. Eur J Cancer 2003;39:517-23.
8. Zochbauer-Muller S, Fong KM, Maitra A et al. 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res 2001;61:3581-5.
9. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998;72:141-96.
10. Barnes LD, Garrison PN, Siprashvili Z et al. Fhit, a putative tumor suppression in humans, is a dinucleoside 5-prime, 5-triple prime-P(1), P(3)-triphosphate hydrolase. Biochemistry 1996;35:111529-35.
11. Graff JR, Greenberg VE, Herman JG. Distinct patterns of E-cadherin CpG island methylation in papillary, gollicular, Hurthle's cell and poorly differentiated human thyroid carcinoma. Cancer Res 1998;58:2063-6.
12. Zou HZ, Yu BM, Wang ZW et al. Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin Cancer Res 2002;8:188-91.
13. Wong IH, Lo YM, Zhang J et al. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 1999;59:71-3.